BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24253281)

  • 21. Distinct Coordination Chemistry of Fe(III)-Based MRI Probes.
    Kras EA; Snyder EM; Sokolow GE; Morrow JR
    Acc Chem Res; 2022 May; 55(10):1435-1444. PubMed ID: 35482819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imidazole-Appended Macrocyclic Complexes of Fe(II), Co(II), and Ni(II) as ParaCEST Agents.
    Burns PJ; Cox JM; Morrow JR
    Inorg Chem; 2017 Apr; 56(8):4546-4555. PubMed ID: 28358208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart Contrast Agents for Magnetic Resonance Imaging.
    Bonnet CS; Tóth É
    Chimia (Aarau); 2016; 70(1-2):102-8. PubMed ID: 26931225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seven coordinate Co(ii) and six coordinate Ni(ii) complexes of an aromatic macrocyclic triamide ligand as paraCEST agents for MRI.
    Pradhan RN; Chakraborty S; Bharti P; Kumar J; Ghosh A; Singh AK
    Dalton Trans; 2019 Jun; 48(24):8899-8910. PubMed ID: 31140528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using frequency-labeled exchange transfer to separate out conventional magnetization transfer effects from exchange transfer effects when detecting ParaCEST agents.
    Lin CY; Yadav NN; Friedman JI; Ratnakar J; Sherry AD; van Zijl PC
    Magn Reson Med; 2012 Apr; 67(4):906-11. PubMed ID: 22287162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward inert paramagnetic Ni(ii)-based chemical exchange saturation transfer MRI agents.
    Caneda-Martínez L; Valencia L; Fernández-Pérez I; Regueiro-Figueroa M; Angelovski G; Brandariz I; Esteban-Gómez D; Platas-Iglesias C
    Dalton Trans; 2017 Nov; 46(43):15095-15106. PubMed ID: 29067395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo imaging of paraCEST agents using frequency labeled exchange transfer MRI.
    Lin CY; Yadav NN; Ratnakar J; Sherry AD; van Zijl PC
    Magn Reson Med; 2014 Jan; 71(1):286-93. PubMed ID: 23468384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
    Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
    Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Frequency-Selective pH-Responsive paraCEST Agent.
    Ratnakar SJ; Chirayil S; Funk AM; Zhang S; Queiró JF; Geraldes CFGC; Kovacs Z; Sherry AD
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21671-21676. PubMed ID: 32726500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectral and thermal studies of divalent transition metal with indole-2-carboxylic acid and 4-substituted hydrazinethiocarbamide.
    Ahmed IT
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Sep; 65(1):5-10. PubMed ID: 16876468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved pH measurements with a single PARACEST MRI contrast agent.
    Sheth VR; Liu G; Li Y; Pagel MD
    Contrast Media Mol Imaging; 2012; 7(1):26-34. PubMed ID: 22344877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutral bis(alpha-iminopyridine)metal complexes of the first-row transition ions (Cr, Mn, Fe, Co, Ni, Zn) and their monocationic analogues: mixed valency involving a redox noninnocent ligand system.
    Lu CC; Bill E; Weyhermüller T; Bothe E; Wieghardt K
    J Am Chem Soc; 2008 Mar; 130(10):3181-97. PubMed ID: 18284242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome.
    Yoo B; Raam MS; Rosenblum RM; Pagel MD
    Contrast Media Mol Imaging; 2007 Jul; 2(4):189-98. PubMed ID: 17712869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of ZnII-activated magnetic resonance imaging agents.
    Major JL; Boiteau RM; Meade TJ
    Inorg Chem; 2008 Nov; 47(22):10788-95. PubMed ID: 18928280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.
    Gupta A; Caravan P; Price WS; Platas-Iglesias C; Gale EM
    Inorg Chem; 2020 May; 59(10):6648-6678. PubMed ID: 32367714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
    Liu G; Li Y; Sheth VR; Pagel MD
    Mol Imaging; 2012 Feb; 11(1):47-57. PubMed ID: 22418027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents.
    Li AX; Hudson RH; Barrett JW; Jones CK; Pasternak SH; Bartha R
    Magn Reson Med; 2008 Nov; 60(5):1197-206. PubMed ID: 18958857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of CEST images in vivo by T1 relaxation: a new approach in the design of responsive PARACEST agents.
    Ratnakar SJ; Soesbe TC; Lumata LL; Do QN; Viswanathan S; Lin CY; Sherry AD; Kovacs Z
    J Am Chem Soc; 2013 Oct; 135(40):14904-7. PubMed ID: 24050192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.